
Zeynep Irem Ozay/X
Jun 1, 2025, 11:40
Zeynep Irem Ozay: High KIM-1/Teff Shows Longer DFS With Adjuvant Atezolizumab vs Placebo
Zeynep Irem Ozay, Postdoctoral Research Fellow at Huntsman Cancer Institute, shared a post on X:
“Brilliant presentation by Sumanta K. Pal at ASCO25!
Genomic analysis from IMmotion010. High KIM-1/Teff shows longer DFS with adjuvant atezolizumab vs placebo”
More posts featuring ASCO25.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 4, 2025, 17:02
Jun 4, 2025, 16:33
Jun 4, 2025, 16:33
Jun 4, 2025, 15:56
Jun 4, 2025, 14:21